Patrick M Sweeney & Associates Inc. Acquires Shares of 3,319 Eastman Chemical (NYSE:EMN)

Patrick M Sweeney & Associates Inc. bought a new stake in Eastman Chemical (NYSE:EMNFree Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm bought 3,319 shares of the basic materials company’s stock, valued at approximately $298,000.

Several other large investors have also made changes to their positions in EMN. Charles Schwab Investment Management Inc. increased its holdings in Eastman Chemical by 2.7% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,108,687 shares of the basic materials company’s stock valued at $99,582,000 after purchasing an additional 29,557 shares during the period. Apollon Wealth Management LLC acquired a new position in Eastman Chemical in the fourth quarter valued at $485,000. Legacy Financial Advisors Inc. grew its holdings in Eastman Chemical by 5.0% during the 4th quarter. Legacy Financial Advisors Inc. now owns 6,722 shares of the basic materials company’s stock worth $604,000 after acquiring an additional 321 shares during the period. Axxcess Wealth Management LLC bought a new position in shares of Eastman Chemical in the 4th quarter worth about $350,000. Finally, M&T Bank Corp lifted its stake in shares of Eastman Chemical by 2.2% in the 4th quarter. M&T Bank Corp now owns 14,338 shares of the basic materials company’s stock valued at $1,288,000 after purchasing an additional 309 shares during the period. Institutional investors and hedge funds own 83.65% of the company’s stock.

Eastman Chemical Stock Performance

Shares of EMN stock traded up $1.89 during trading hours on Tuesday, hitting $100.64. 1,100,801 shares of the company were exchanged, compared to its average volume of 1,078,508. Eastman Chemical has a 52-week low of $68.89 and a 52-week high of $102.71. The company has a current ratio of 1.39, a quick ratio of 0.71 and a debt-to-equity ratio of 0.77. The firm has a fifty day simple moving average of $95.26 and a 200 day simple moving average of $87.55. The stock has a market capitalization of $11.84 billion, a price-to-earnings ratio of 12.73, a P/E/G ratio of 1.06 and a beta of 1.54.

Eastman Chemical (NYSE:EMNGet Free Report) last issued its earnings results on Thursday, April 25th. The basic materials company reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.41 by $0.20. The firm had revenue of $2.31 billion for the quarter, compared to analyst estimates of $2.29 billion. Eastman Chemical had a return on equity of 13.84% and a net margin of 10.16%. The business’s revenue was down 4.2% on a year-over-year basis. During the same period in the previous year, the company posted $1.63 earnings per share. Research analysts predict that Eastman Chemical will post 7.75 earnings per share for the current fiscal year.

Eastman Chemical Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, July 9th. Stockholders of record on Monday, June 17th will be paid a $0.81 dividend. The ex-dividend date of this dividend is Monday, June 17th. This represents a $3.24 annualized dividend and a dividend yield of 3.22%. Eastman Chemical’s payout ratio is 41.75%.

Insider Activity

In other Eastman Chemical news, SVP Adrian James Holt sold 4,735 shares of the firm’s stock in a transaction dated Wednesday, March 6th. The stock was sold at an average price of $87.75, for a total value of $415,496.25. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 2.28% of the company’s stock.

Wall Street Analyst Weigh In

EMN has been the topic of a number of research analyst reports. KeyCorp increased their price target on Eastman Chemical from $101.00 to $121.00 and gave the stock an “overweight” rating in a report on Tuesday, April 9th. Barclays raised their price target on shares of Eastman Chemical from $85.00 to $103.00 and gave the stock an “equal weight” rating in a report on Monday. Royal Bank of Canada upped their price objective on shares of Eastman Chemical from $100.00 to $104.00 and gave the company a “sector perform” rating in a report on Tuesday, April 30th. Wells Fargo & Company raised their target price on Eastman Chemical from $89.00 to $100.00 and gave the company an “equal weight” rating in a research note on Thursday, April 11th. Finally, Piper Sandler boosted their target price on Eastman Chemical from $90.00 to $105.00 and gave the company a “neutral” rating in a research report on Tuesday, April 30th. Eight analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $104.18.

View Our Latest Analysis on EMN

About Eastman Chemical

(Free Report)

Eastman Chemical Company operates as a specialty materials company in the United States, China, and internationally. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants, and organic acid-based solutions; specialty coalescent and solvents, paint additives, and specialty polymers; and heat transfer and aviation fluids.

See Also

Want to see what other hedge funds are holding EMN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Eastman Chemical (NYSE:EMNFree Report).

Institutional Ownership by Quarter for Eastman Chemical (NYSE:EMN)

Receive News & Ratings for Eastman Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eastman Chemical and related companies with MarketBeat.com's FREE daily email newsletter.